tiprankstipranks
Demant (WILYY)
OTHER OTC:WILYY

Demant (WILYY) Price & Analysis

Compare
2 Followers

WILYY Stock Chart & Stats


---

Financials

Quarterly

WILYY FAQ

What was Demant’s price range in the past 12 months?
Demant lowest stock price was $18.00 and its highest was $27.00 in the past 12 months.
    What is Demant’s market cap?
    Demant’s market cap is $8.42B.
      When is Demant’s upcoming earnings report date?
      Demant’s upcoming earnings report date is Aug 12, 2025 which is in 186 days.
        How were Demant’s earnings last quarter?
        Currently, no data Available
        Is Demant overvalued?
        According to Wall Street analysts Demant’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Demant pay dividends?
          Demant does not currently pay dividends.
          What is Demant’s EPS estimate?
          Demant’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Demant have?
          Demant has 442,179,600 shares outstanding.
            What happened to Demant’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Demant?
            Currently, no hedge funds are holding shares in WILYY
            ---

            Demant Stock Smart Score

            3
            Underperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -19.81%
            12-Months-Change

            Fundamentals

            Return on Equity
            28.73%
            Trailing 12-Months
            Asset Growth
            6.49%
            Trailing 12-Months

            Company Description

            Demant

            Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices (87% of sales), implants (4%), and audio diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
            ---

            WILYY Company Deck

            ---

            WILYY Earnings Call

            Q4 2025
            0:00 / 0:00
            Earnings Call Sentiment|Neutral
            The earnings call highlighted the company's strong cash flow and strategic advancements in sustainability and hearing care. However, these were counterbalanced by challenges such as the decline in EBIT, loss of market share in the U.S., and issues in the diagnostic segment. Despite the positive outlook, the balance between highlights and lowlights suggests a cautious stance.Read More>
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Align Tech
            Medtronic
            Steris
            Watsco
            Sonova Holding AG
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis